160 related articles for article (PubMed ID: 34344239)
1. Anticancer activity and toxicity of new quaternary ammonium geldanamycin derivative salts and their mixtures with potentiators.
Skrzypczak N; Pyta K; Ruszkowski P; Mikołajczak P; Kucińska M; Murias M; Gdaniec M; Bartl F; Przybylski P
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1898-1904. PubMed ID: 34344239
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
Skrzypczak N; Pyta K; Ruszkowski P; Gdaniec M; Bartl F; Przybylski P
Eur J Med Chem; 2020 Sep; 202():112624. PubMed ID: 32663707
[TBL] [Abstract][Full Text] [Related]
3. Modifications of geldanamycin via CuAAC altering affinity to chaperone protein Hsp90 and cytotoxicity.
Skrzypczak N; Buczkowski A; Bohusz W; Nowak E; Tokarska K; Leśniewska A; Alzebari AM; Ruszkowski P; Gdaniec M; Bartl F; Przybylski P
Eur J Med Chem; 2023 Aug; 256():115450. PubMed ID: 37210951
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of macbecin as an Hsp90 inhibitor.
Martin CJ; Gaisser S; Challis IR; Carletti I; Wilkinson B; Gregory M; Prodromou C; Roe SM; Pearl LH; Boyd SM; Zhang MQ
J Med Chem; 2008 May; 51(9):2853-7. PubMed ID: 18357975
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel 17-phenylethylaminegeldanamycin derivatives as potent Hsp90 inhibitors.
Li Z; Jia L; Wang J; Wu X; Shi G; Lu C; Shen Y
Chem Biol Drug Des; 2015 Feb; 85(2):181-8. PubMed ID: 24903735
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites.
Lee K; Ryu JS; Jin Y; Kim W; Kaur N; Chung SJ; Jeon YJ; Park JT; Bang JS; Lee HS; Kim TY; Lee JJ; Hong YS
Org Biomol Chem; 2008 Jan; 6(2):340-8. PubMed ID: 18175003
[TBL] [Abstract][Full Text] [Related]
7. Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
Li Z; Jia L; Wang J; Wu X; Hao H; Wu Y; Xu H; Wang Z; Shi G; Lu C; Shen Y
Eur J Med Chem; 2014 Nov; 87():346-63. PubMed ID: 25277067
[TBL] [Abstract][Full Text] [Related]
8. New C-19-modified geldanamycin derivatives: synthesis, antitumor activities, and physical properties study.
Liu YF; Zhong JJ; Lin L; Liu JJ; Wang YG; He WQ; Yang ZY
J Asian Nat Prod Res; 2016 Aug; 18(8):752-64. PubMed ID: 26988280
[TBL] [Abstract][Full Text] [Related]
9. Potent cytotoxic C-11 modified geldanamycin analogues.
Tian ZQ; Wang Z; MacMillan KS; Zhou Y; Carreras CW; Mueller T; Myles DC; Liu Y
J Med Chem; 2009 May; 52(10):3265-73. PubMed ID: 19405528
[TBL] [Abstract][Full Text] [Related]
10. New synthetic aliphatic sulfonamido-quaternary ammonium salts as anticancer chemotherapeutic agents.
Song D; Yang JS; Oh C; Cui S; Kim BK; Won M; Lee JI; Kim HM; Han G
Eur J Med Chem; 2013 Nov; 69():670-7. PubMed ID: 24095759
[TBL] [Abstract][Full Text] [Related]
11. An improved route to 19-substituted geldanamycins as novel Hsp90 inhibitors--potential therapeutics in cancer and neurodegeneration.
Kitson RR; Moody CJ
Chem Commun (Camb); 2013 Oct; 49(76):8441-3. PubMed ID: 23770604
[TBL] [Abstract][Full Text] [Related]
12. 19-[(1'S,4'R)-4'-Hydroxy-1'-methoxy-2'-oxopentyl]geldanamycin, a natural geldanamycin analogue from Streptomyces hygroscopicus 17997.
Li S; Ni S; Wu L; Li L; Jiang B; Wang H; Sun G; Gan M; Li J; He W; Lin L; Wang Y; Bai S; Si S
J Nat Prod; 2013 May; 76(5):969-73. PubMed ID: 23656556
[TBL] [Abstract][Full Text] [Related]
13. [Anticancer effect of 17-(6-cinnamamido-hexylamino-)-17-demethoxygeldanamycin: in vitro and in vivo].
Li L; Liu H; Zhang SH; Hu L; Zhen YS
Yao Xue Xue Bao; 2013 Dec; 48(12):1771-7. PubMed ID: 24689233
[TBL] [Abstract][Full Text] [Related]
14. Folate receptor-targeted hybrid lipid-core nanocapsules for sequential delivery of doxorubicin and tanespimycin.
Gupta B; Pathak S; Poudel BK; Regmi S; Ruttala HB; Gautam M; Lee JS; Jeong JH; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2017 Jul; 155():83-92. PubMed ID: 28410515
[TBL] [Abstract][Full Text] [Related]
15. New geldanamycin derivatives with anti Hsp properties by mutasynthesis.
Hermane J; Eichner S; Mancuso L; Schröder B; Sasse F; Zeilinger C; Kirschning A
Org Biomol Chem; 2019 May; 17(21):5269-5278. PubMed ID: 31089638
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo Evaluation of 17-phenylpropylamine/phenoxyethylamine- 17-demethoxygeldanamycins as Potent Hsp90 Inhibitors.
Li Z; Jia L; Xu H; Lu C; Shena Y
Med Chem; 2015; 11(5):482-8. PubMed ID: 25537129
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and structure--activity relationships for chimeric inhibitors of Hsp90.
Shen G; Wang M; Welch TR; Blagg BS
J Org Chem; 2006 Sep; 71(20):7618-31. PubMed ID: 16995666
[TBL] [Abstract][Full Text] [Related]
18. Non-Benzoquinone Geldanamycin Analog, WK-88-1, Induces Apoptosis in Human Breast Cancer Cell Lines.
Zhao YR; Li HM; Zhu M; Li J; Ma T; Huo Q; Hong YS; Wu CZ
J Microbiol Biotechnol; 2018 Apr; 28(4):542-550. PubMed ID: 29618179
[TBL] [Abstract][Full Text] [Related]
19. Hsp90 inhibitor geldanamycin enhances the antitumor efficacy of enediyne lidamycin in association with reduced DNA damage repair.
Han FF; Li L; Shang BY; Shao RG; Zhen YS
Asian Pac J Cancer Prev; 2014; 15(17):7043-8. PubMed ID: 25227788
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors.
Li Z; Jia L; Wang J; Wu X; Hao H; Xu H; Wu Y; Shi G; Lu C; Shen Y
Eur J Med Chem; 2014 Oct; 85():359-70. PubMed ID: 25105924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
